HAPPY HOLIDAYS FROM THE ARORA REPORT
December 24, 2014
Merry Christmas and Happy Holidays from all of us at The Arora Report.
Proven Track Record of Most Accurate Analysis
Proven Track Record
of Most Accurate Analysis
Merry Christmas and Happy Holidays from all of us at The Arora Report.
(The Weekly Digest reproduces the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers. ) FORTUITOUS TIMING BEFORE THE MONSTER RALLY BUT SHY AWAY FROM EXUBERANCE December 19, 2014 In two days, the stock market rose about 700 DJIA points from the low. On the day of the low, ZYX Buy Change Alert headline, “NO STOCK MARKET CRASH, ANY FURTHER DIP WILL BE A BUYING OPPORTUNITY, AND REDUCING THE HEDGE.” It is important to understand the rally and shy away from exuberance. A big part of yesterday’s rally is
In two days, the stock market rose about 700 DJIA points from the low. On the day of the low, ZYX Buy Change Alert headline, “NO STOCK MARKET CRASH, ANY FURTHER DIP WILL BE A BUYING OPPORTUNITY, AND REDUCING THE HEDGE.” The above chart tells the story. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE 30 day trial. Check out our enviable performance in both bull and bear markets.
This post was just published on ZYX Buy Change Alert. BLCM is long with an average price of $19. As of this writing it is trading at $25.84. Consider taking profits on a 20% tranche in the zone of $25 to $26.73. Also consider stops on a 20% tranche in the zone of $24.13 to $24.38, and stops on another 20% tranche in the zone of $22.13 to $22.43. Stop on the remaining 40% in the zone of $21.23 to $21.38. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE
This post was published on ZYX Buy Change Alert. JUNO is developing immunotherapies for lymphomas, leukemias and other cancers. It is an upcoming IPO This is a call to buy in the IPO at the IPO price. To be clear, this is not a call to buy the stock post IPO or in the open market when the stock starts trading. Consider contacting your broker and requesting up to 150% of the full core position size. Consider buying only if the IPO is priced under $21, preferably under $20. Hard stops are mandatory in the zone of $0.01 below the offering price
This post was published on ZYX Buy Change Alert. BLCM is a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including both hematological cancers and solid tumors, as well as orphan inherited blood disorders. It is an upcoming IPO This is a call to buy in the IPO at the IPO price. To be clear, this is not a call to buy the stock post IPO or in the open market when the stock starts trading. Consider contacting your broker and requesting up to 100% of the full core position size. Consider
This post was just published on ZYX Buy Change Alert. RAD is long from an average of $4.96 and 70% of the full core position size is being held. In the premarket as of this writing RAD is trading at $6.72. Consider taking profits on a 10% tranche in the zone of $6.60 to $7.38. Consider holding the remaining 60%. The move up in the premarket is the result of much better than expected earnings. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click
This post was just published on ZYX Short Change Alert. Take profits and exit VA in the zone of $29. to $31.43. The stock is trading at $31.31 as of this writing. You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES. Please click here to take advantage of a FREE 30 day trial. Check out our enviable performance in both bull and bear markets.